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Table I: Characteristics of Studies: 
Study  Size 
(n) 
Population Exclusion Study 
Design 
Delirium 
Incidence 
(%) 
Delirium 
Assessment 
Tool 
Testing Country Age NOS 
Benoit 
2005 
102 Aortic 
aneurysm 
repair 
Hearing/Visual 
Impairment 
Prospective 
Cohort 
34 DSM 
IV/DOS 
Symptom 
driven 
Canada 71 
(8) 
7 
Bohner 
2003 
153 Elective >24 hrs 
ventilator 
Prospective 
Cohort 
39.2 DSM 
IV/DRS 
Daily Germany 66 
(10) 
8 
Bryson 
2011 
84 Elective open 
aortic 
aneurysms 
(Age>60) 
Dementia/psych 
illness, 
substance abuse 
Prospective 
Cohort 
36 CAM Day 2,4, 
and 
discharge 
Canada 71 
(6) 
7 
Ellard 
2014 
500 Open 
aneurysms and 
carotid 
endarterectomy 
excluded 
Dementia, 
abnormal 
consciousness 
Retrospective 
Cohort 
19.4 NEECHAM Daily  Canada 72 
(12) 
5 
Katznelson 
2009 
582 Carotid 
endarterectomy 
excluded 
Dementia, 
abnormal 
consciousness, 
short admission 
(<24 hours), 
multiple 
procedures 
Prospective 
Cohort 
22 NEECHAM Daily  Canada 68 
(12) 
8 
Koebrugge 
2010 
107 Aorto-illiac 
surgery 
Dementia Prospective 
Cohort 
23 DSM-IV, 
DOS 
3 x daily Netherlands 69 
(10) 
7 
Pol 2011 142 All Vascular 
Surgery 
None Prospective 
Cohort 
7 DSM-IV-
TR, DOS 
Symptom 
driven 
Netherlands 68 
(11) 
6 
  
Pol 2014 277 Carotid 
endarterectomy 
excluded  
None Prospective 
Cohort 
6 DSM-IV-
TR, DOS 
Symptom 
driven 
Netherlands 69 
(11) 
6 
Raats 2015 206 Ward patients Short admission 
(<48 hours) 
Prospective 
Cohort 
15.5 DOS 3 x daily Netherlands 73 
(9) 
6 
Salata 
2012 
256 Aortic 
aneurysm 
repair 
Dementia, 
abnormal 
consciousness 
Retrospective 
Cohort 
22 NEECHAM Daily Canada 71 
(10) 
6 
Sasajima 
2000 
110 Lower limb 
ischemia 
(Age>60) 
None Prospective 
Cohort 
29.1 CAM Daily Japan 72 
(7) 
7 
Sasajima 
2012 
299 Lower limb 
ischemia 
(Age>60) 
None Prospective 
Cohort 
29 CAM, DRS Symptom 
driven 
Japan 72 
[10] 
7 
Schneider 
2002 
47 Elective only Short operations 
(<90mins) 
Prospective 
Cohort 
36 DSM IV, 
DRS 
Daily Germany 67 
(7) 
8 
Sugimoto 
2015 
397 Open aortic 
aneurysm 
repair 
None Retrospective 
Cohort 
11.5 DSM IV Symptom 
driven 
Japan 72 
[10] 
8 
Van 
Eijsden 
2015 
92 Lower limb 
ischemia 
None Retrospective 
Cohort 
32 DOS, DSM 
IV 
3 x daily Netherlands 76 
[11] 
7 
Visser 
2015 
463 All vascular 
surgery 
(Age>60) 
Endovascular 
without 
stenting, 
short/no 
hospital 
admission 
Prospective 
Cohort 
4.8 DSM IV, 
DOS 
3 x daily Netherlands 72 
[11] 
7 
Totals 3817 
 
  23.4 
 
    
  
Table I: Characteristics of Studies: DSM - Diagnostic and Statistical Manual of Mental Disorders, CAM - Confusion Assessment 
Method, NEECHAM - NEECHAM Confusion Scale, DRS - Delirium Rating Scale, DOS - Delirium Observation Scale, NOS – Newcastle 
Ottawa Scale. Incidence reflects unweighted cumulative sum.  
  
 
  
  
Table II: Newcastle-Ottowa Scoring 
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Selection                                  
Representativeness 
of exposed cohort  
+ + + + + + + + + + + + + + + + 
Selection of non-
exposed cohort  
+ + + + + + + + + + + + + + + + 
Ascertainment of 
exposure  
+ + + + + + + + + + + + + + + + 
Demonstration 
outcome of interest 
not present at start 
of study  
  
+ 
 
+ 
           
Comparability                                  
Study controls for 
age  
+ + 
  
+ + + + + + + + + + + + 
Controls for 
additional factor  
+ + 
  
+ + + + + + + + + + + + 
Outcome                                  
Assessment of 
outcome  
+ + + + + + + + + + + + + + + + 
Length of follow-
up  
+ + + + + 
     
+ + + + + 
 
Adequacy of cohort 
follow-up  
 
+ + 
  
+ 
      
+ + 
 
+ 
Score  7 8 7 5 8 7 6 6 6 6 7 7 8 8 7 7 
Table II: Newcastle Ottawa Scoring 
  
Table III: Significant Risk Factors in Multivariate Models.   
Risk Factors Study OR (95% CI) / [SE]  
/ *b 
P 
Patient Factors    
Absence of High Lipids Sugimoto 2015 2.15 (1.06 to 4.37) .034 
Age Katznelson 2009 1.04 (1.02 to 1.07) <.001 
Age Salata 2012 1.04 (1.00 to 1.08) .04 
Age>64 Bohner 2003 3.03 [SE 0.47] .018 
Age≥70 Sasajima 2000 14.1 (2.7 to 72.0) .002 
Age≥72 Sasajima 2000 5.1 (2.8 to 10.7) <.0001 
Age≥70 Sugimoto 2015 3.34 (1.44 to 7.77) .005 
Age≥80 Visser 2015 7.3 (1.8 to 30.1) .006 
Amphia Risk score Raats 2015 1.77 (1.04 to 3.02) .04 
Cognitive Impairment Visser 2015 16.4 (4.7 to 57.0) <.001 
CRP>5 Pol 2014 1.01 (1.00 to 1.03) .04 
Current smoker Visser 2015 10.5 (2.8 to 40.2) .001 
Diabetes Van Eijsden 2015 6.23 (1.11 to 52.2) .035 
Depression Katznelson 2009 3.56 (1.53 to 8.28) .003 
End Stage Renal Failure Sasajima 2000 5.0 (1.9 to 13.0) .001 
HDS-R≥20 Sasajima 2000 2.8 (1.4 to 5.6) .003 
Height <170cm Bohner 2003 3.95 [SE 0.47] .004 
History of CVA/TIA Katznelson 2009 2.64 (1.57 to 4.45) <.001 
History of major amputation Bohner 2003 24.4 [SE 0.95] .001 
  
Hypertension Visser 2015 7.6 (1.9 to 30.5) .004 
MMSE Schneider 2002 -0.08* .0007 
MMSE <25 Bohner 2003 28.0 [SE 0.93] .001 
No history of supra-aortic occlusive 
disease 
Bohner 2003 6.73 [SE 0.60] .001 
Nurse help pre admission Raats 2015 3.61 (1.13 to 11.49) .03 
Pre op Beta Blocker Katznelson 2009 2.06 (1.18 to 3.60) .011 
Pre op Statin Katznelson 2009 0.56 (0.37 to 0.88) .011 
SNAQ-RC≥3 Van Eijsden 2015 5.55 (1.07 to 42.0) .039 
Peri-Operative Factors    
Amputation Katznelson 2009 4.66 (1.96 to 11.09) <.001 
Aortic reconstruction Katznelson 2009 5.34 (2.54 to 11.20) <.001 
Blood Loss≥1517ml Sugimoto 2015 2.71 (1.36 to 5.39) .005 
Critical Limb Ischemia (vs. 
Claudication) 
Sasajima 2000 2.0 (1.1 to 3.6) .034 
Infusion Schneider 2002 0.0001* .0094 
Intra op colloid >800ml Bohner 2003 2.62 [SE 0.46] .035 
Intra op minimal potassium 
<3.5mmol/L 
Bohner 2003 3.18 [SE 0.50] .021 
Multiple segment occlusion Sasajima 2000 2.9 (1.6 to 5.3) <.0001 
Open Vs EVAR Salata 2012 0.32 (0.16 to 0.73) .005 
Thrombectomy/Embolectomy Katznelson 2009 3.27 (1.41 to 7.60) .006 
Transfusion Schneider 2002 0.0005* .0069 
  
Type of procedure Visser 2015 14.0 (3.9 to 49.8) <.001 
Post-Operative Factors None   
Table III: Summary of Risk factors analysed in multivariate models. *b – Parameter estimated 
from multiple regression analysis. 
MMSE – Mini Mental State Examination, SNAQ-RC – Short Nutritional Assessment Questionnaire 
(version for elderly inpatients), CVA-Cerebrovascular accident, TIA-Transient ischemic attack. 
HDS-R - Hierarchic Dementia Scale-Revised. 
 
  
  
Table IV: Meta-Analysis of Risk Factors (Minimum 4 studies) 
Outcome or 
Subgroup 
Studies Participants Statistical 
Method 
Effect Estimate 
OR [95%CI] 
/MD(95%CI) 
I2 
Patient Factors      
ASA>2 5 1180 M-H, Fixed *3.44 [2.02, 5.87] 49% 
Diabetes Mellitus 7 2149 M-H, Random 1.40 [0.86, 2.27] 69% 
eGFR<60 5 1180 M-H, Fixed *2.09 [1.23, 3.56] 0% 
History of 
stroke/TIA 
4 1552 M-H, Fixed *1.87 [1.31, 2.67] 48% 
Hypercholesterol
aemia 
4 848 M-H, Fixed *0.40 [0.27, 0.59] 0% 
Hypertension 7 2149 M-H, Random 1.50 [0.94, 2.39] 48% 
Male 11 2777 M-H, Fixed *1.30 [1.01, 1.67] 0% 
Mean Age 10 2226 IV, Fixed *4.99 (4.02, 5.95) 0% 
Neurological 
Comorbidity 
4 699 M-H, Fixed *1.57 [1.06, 2.31] 0% 
Peri-operative 
Factors 
     
General 
Anaesthesia 
5 1461 M-H, Fixed 0.94 [0.69, 1.29] 46% 
  
Length of Op 
(min) 
4 472 IV, Fixed 16.09 (-0.98, 
33.17) 
48% 
Mean Pre-
operative Hb 
(g/dL) 
4 889 IV, Fixed *-0.66 (-0.98, -
0.33) 
0% 
Post-operative 
Factors 
     
Days in ICU 5 519 IV, Random *1.06 (0.39, 1.73) 60% 
Table IV: Meta -Analysis of Risk Factors. * indicate statistically significant (p<.05). OR- Odds 
Ratio, MD – Mean Difference, I2 – Higgins I2 measurement of heterogeneity, Hb – Haemoglobin, 
eGFR – estimated glomerular filtration rate, M-H – Mantel–Haenszel, IV – Inverse-Variance. 
  
  
Supplementary Table I Validated delirium assessment tools used in included papers 
Tool Description Criteria 
DSM-IV5 
(DSM-V is the 
updated version of the 
DSM criteria, but is 
not yet used widely) 
Standard for diagnosis of 
delirium. Should meet all 
of the features described 
Disturbance of consciousness with reduced 
ability to focus, sustain or shift attention 
Change in cognition or development of a 
perceptual disturbance that is not better 
accounted for by a dementia 
The disturbance develops over a short period 
of time and tends to fluctuate during the 
course of the day 
There is evidence from the history, physical 
examination or laboratory findings that 
the disturbance is caused by the direct 
physiological consequences of a general 
medical condition 
Confusion Assessment 
Method7 
Based on DSM criteria. 
Two primary criteria 
required for diagnosis plus 
one of a further two 
Acute onset and Fluctuating course and 
Inattention  
Plus 
Disorganized speech or 
Altered level of consciousness 
Delirium Rating 
Scale8 
6-point clinician-rated 
scale in two sections 
First section comprises a three-item 
diagnostic section. The second section scores 
  
severity based on 13 items 
Neecham Confusion 
Scale9 
0–19 points, moderate to  
     severe confusion 
20–24 points, mild or early  
     delirium 
25–30 points, normal 
 
Level of responsiveness–information 
processing 
Attention and alertness (0–4) 
Verbal and motor response (0–5) 
Memory and orientation (0–5) 
Level of behaviour 
General behaviour and posture (0–2) 
Sensory motor performance (0–4) 
Verbal responses (0–4) 
Vital functions 
Vital signs (0–2) 
Oxygen saturations (0–2) 
Incontinence (0–2) 
Delirium Observation 
Scale10 
13 domains 
0 points, never 
1 point, sometimes or 
always  
 
*Scored inversely 
Dozes during conversation or activities 
Is easy distracted by stimuli from the 
environment 
Maintains attention to conversation or 
action* 
Does not finish question or answer 
Gives answers which do not fit the question 
Reacts slowly to instructions 
  
Thinks to be somewhere else 
Knows which part of the day it is* 
Remembers recent event* 
Is picking, disorderly, restless 
Pulls intravenous tubes, feeding tubes, 
catheter, etc. 
Is easily or suddenly emotional 
Sees people/things as somebody/thing else 
  
  
Supplementary Table II: Univariate analysis of risk factors 
+ (increased delirium risk), = (not significant), - (decreased delirium risk) 
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Demographics 
               
Mean height  = + 
              
Mean Weight = = 
              
Gender = 
   
= = = = = 
 
+ + 
 
= = = 
Age = + 
 
+ + + = = + 
 
+ + = + + + 
Total years of 
education 
= 
               
Maritial status = 
               
Living status 
(alone or not) 
= 
       
= 
       
BMI 
     
= 
    
= = 
   
= 
Nursing help 
at home 
        
= 
     
= 
 
Nursing home 
resident 
        
+ 
     
+ 
 
                 
Pre op Measurements 
             
Systolic BP = 
    
= 
          
  
Diastolic BP  = 
    
+ 
          
Heart rate 
     
= 
          
WCC 
 
= 
        
+ 
     
Platelets 
 
= 
        
= 
     
LFTs 
 
= 
              
Creatinine 
 
= 
  
= = 
       
= 
  
Urea  
 
= 
   
+ 
    
= + 
 
+ 
  
Protein 
 
= 
              
Coagulation 
 
= 
              
Glucose 
 
= 
              
Sodium 
 
= 
        
= = 
    
Potassium 
 
= 
        
= = 
    
Calcium 
 
= 
              
Haemoglobin  
 
+ 
  
+ = = = 
  
= = = 
 
+ = 
ATIII  
 
+ 
              
CRP  
 
+ 
    
= 
        
+ 
APOE gene 
  
= 
             
eGFR<60 
      
+ = = 
     
= = 
Leukocyte 
count 
      
= 
         
Median AP 
          
+ + 
    
TP<6.0 
          
= = 
    
Albumin<3.8 
          
+ + 
    
  
A/G<1.31 
          
= + 
    
T-CHO>240 
          
= 
     
CPK>195 
          
= 
     
Cl<96 or >110 
          
= = 
    
FEV1 
             
+ 
  
%VC 
             
+ 
  
Ejection 
Fraction % 
             
= 
  
                 
Past Medical History 
              
History of 
head injury 
= 
               
Neurological 
comorbidity 
= 
   
+ 
   
+ 
 
= = 
 
+ = = 
No of 
psychoactive 
medications 
= 
               
No of 
vasoactive 
medications 
+ 
               
Peripheral 
Vascular 
Disease 
 
= 
              
  
History of 
POD 
 
= 
      
+ 
     
+ 
 
Hypercholeste
roleamia  
 
- 
 
= = 
   
= 
    
- + 
 
Hearing 
Impairment 
              
= 
 
Visual 
Impairment 
 
= 
            
+ 
 
Previous 
Vascular 
surgery 
 
+ 
              
Major 
amputation 
 
+ 
              
Femoral neck 
fracture 
 
+ 
              
Psychiatric 
Disease 
 
= 
              
Beta Blocker 
use 
   
+ = 
           
Diabetes 
    
= 
   
= 
 
= = 
 
= = + 
Hypertension 
    
= 
   
= 
 
= = 
 
= = + 
IHD 
    
= 
        
= 
  
Depression 
    
+ 
  
+ 
       
= 
  
No of 
diagnosis 
     
= 
          
No of 
medications 
     
= 
          
Cognitive 
Impairment 
       
+ + 
      
+ 
Cardiac 
Comorbidity 
        
+ 
  
= 
  
+ 
 
Pulmonary 
comorbidity 
        
= 
     
= 
 
COPD 
             
= 
 
= 
Active Malign 
Neoplasm 
        
= 
       
Non active 
malign 
neoplasm 
        
= 
       
Severity of 
Ischemia 
(Claudication 
Vs CLI) 
          
+ + 
    
Type of 
occlusion 
          
= + 
    
  
(Single Vs 
Multiple) 
End stage 
renal disease 
           
+ 
 
= 
  
                 
Scoring Systems 
               
GDS = 
               
DOS>3 
      
+ 
         
ASA 
 
= 
   
+ + = + 
   
= 
 
+ = 
HAMD  
 
+ 
          
+ 
   
BPRS  
 
+ 
          
+ 
   
ASGS  
 
+ 
          
+ 
   
GAS  
 
+ 
          
+ 
   
MMSE  
 
+ 
          
+ 
   
CCI 
     
= + = 
       
+ 
Median GFI 
      
+ 
         
KATZ <6 
              
+ 
 
KATZ=<5 
        
+ 
       
SNAQ>=3 
        
= 
     
= 
 
Mean Amphia 
Risk Score 
        
+ 
       
HDS-R 
          
+ + 
    
Fontaine  
           
+ 
  
+ 
 
NHYA Class 
             
= 
  
  
                 
Lifestyle 
                
Alcohol = = 
      
= 
     
+ 
 
Smoking + + 
           
= 
 
+ 
Alcohol Abuse 
 
= 
              
Benzodiazepin
e Abuse 
 
= 
              
                 
Intraoperative factors 
              
Length of op = = 
   
+ 
    
+ + 
 
= 
 
= 
Max AAA 
diameter 
= 
               
Aortic cross 
clamp time 
= = 
              
Type of 
Operation  
 
= 
  
= = 
 
+ 
        
Minor 
amputation 
              
= 
 
Major 
amputation 
              
+ 
 
Bypass 
              
+ 
 
Femoral 
endarterectom
y 
              
= 
 
  
Amputation 
    
+ 
         
= 
 
Aorto-illiac 
occlusive 
disease 
     
+ 
          
Type of 
bypass 
           
= 
    
Laparotomy/E
ndovascular 
     
= 
          
Type of 
operation 
(Aortic Vs 
Non-Aortic) 
 
+ 
              
Emergency/El
ective 
   
+ 
 
+ 
          
Type of 
Anaesthesia 
   
= 
 
= 
     
= 
 
= = = 
Renal artery 
clamping 
             
= 
  
Type of AAA 
procedure 
= = 
   
= 
          
Crystalloid 
volume  
 
+ 
   
+ 
      
+ 
   
Blood loss 
 
+ 
   
+ 
      
= + 
 
+ 
  
Autotransfusio
n 
            
= 
   
Minimal temp 
 
+ 
              
Minimal Hb 
 
+ 
   
+ 
      
= 
   
Minimal pH 
 
+ 
              
Minimal base 
excess 
 
+ 
              
Minimal 
sodium 
 
+ 
              
Minimal 
potassium 
 
+ 
              
Minimal CVP 
 
+ 
              
Length of 
anaesthesia 
 
= 
            
+ 
 
Intra op BP 
 
=* 
              
Intra op ABG 
 
=* 
              
Intra op 
Glucose 
 
=* 
              
Intra op 
additional Ca 
 
+ 
              
Intra op 
Atropine 
 
+ 
              
  
Lowest 
systolic BP 
     
= 
          
Lowest 
diastolic BP 
     
= 
          
Heart rate  
     
+ 
          
Intra op blood 
transfusion 
          
= + + 
   
Minimal Pao2 
            
= 
   
Sodium 
Bicarbonate  
            
+ 
   
                 
Post-Operative Factors 
              
Admitted to 
ICU 
      
+ + 
      
= 
 
Days in ICU = + 
   
+ 
    
+ 
 
= 
 
= 
 
Days in 
Hospital 
= + 
 
+ 
 
+ + 
       
+ 
 
Need for 
transfusion 
 
+ 
            
= 
 
ABGs 
 
=* 
              
Need for FFP 
 
+ 
              
Removed 
cannula or 
catheter 
 
+ 
              
  
Cannula or 
catheter 
infection 
 
+ 
              
Reintubation 
 
+ 
              
Need for resus 
 
+ 
              
Redo surgery 
 
+ 
         
= 
    
Unstable 
hypertension 
 
+ 
              
Post op Hb  
 
+ 
   
= 
      
+ 
 
= 
 
Minimal 
Platelets 
 
+ 
              
Total protein 
 
+ 
              
B blocker use 
    
= 
           
Urea at 
discharge 
     
= 
          
Creatinine at 
discharge 
     
= 
          
No of 
complications 
     
+ 
 
= 
        
Mortality 
     
+ 
          
CRP 
       
+ 
        
Cardiac 
complication 
              
= 
 
  
Pulmonary 
complication 
              
= 
 
Neurological, 
renal or 
urinary 
complication 
              
+ 
 
Wound 
infection 
              
= 
 
Re-bleeding 
requiring 
intervention 
              
= 
 
Wound 
dehiscence 
              
= 
 
New NH 
resident at 
discharge 
              
= 
 
 
  
  
Supplementary Table III - Meta-Analysis of Risk Factors 
Outcome or Subgroup Studies Participants Statistical 
Method 
Effect Estimate 
OR[95%CI]/MD(
95%CI) 
I2 
Patient Demographics      
Mean Age 10 2226 IV, Fixed *4.99 (4.02, 5.95) 0% 
Male 11 2777 M-H, Fixed *1.30 [1.01, 1.67] 0% 
Height 2 255 IV, Fixed *-2.38 (-4.60, -
0.16) 
0% 
Weight 2 255 IV, Fixed -3.06 (-6.84, 0.73) 0% 
Lives Alone 2 308 M-H, Fixed 1.29 [0.70, 2.38] 17% 
Mean BMI 2 217 IV, Fixed 0.68 (-0.36, 1.71) 19% 
Nursing Home Resident 2 298 M-H, Fixed *5.69 [2.77, 11.68] 0% 
Pre-Op Measurements      
Pre-op Systolic BP (mmHg) 2 209 IV, Random -3.17 (-14.55, 
8.22) 
63% 
Pre op Diastolic BP (mmHg) 2 209 IV, Random -2.38 [-8.26, 3.50] 54% 
Mean Pre-Op Hb (g/dl) 4 889 IV, Fixed *-0.66 (-0.98, -
0.33) 
0% 
  
Past Medical History      
Daily Use of Alcohol 2 298 M-H, Random 0.44 [0.10, 1.82] 61% 
Current Smoker 3 771 M-H, Random 1.71 [0.56, 5.25] 79% 
Any Time Smoker 3 1013 M-H, Random 1.42 [0.65, 3.08] 58% 
eGFR<60 5 1180 M-H, Fixed *2.09 [1.23, 3.56] 0% 
Neurological Comorbidity 4 699 M-H, Fixed *1.57 [1.06, 2.31] 0% 
History of Delirium 2 298 M-H, Fixed *7.49 [3.25, 17.28] 0% 
Visual Impairment 2 245 M-H, Fixed *2.16 [1.25, 3.74] 0% 
Beta Blocker Use Pre Op 2 1082 M-H, Fixed *1.70 [1.21, 2.39] 0% 
Hypercholesterolaemia 4 848 M-H, Fixed *0.40 [0.27, 0.59] 0% 
Statin Use 2 994 M-H, Fixed *0.73 [0.54, 0.97] 0% 
History of CVA/TIA 4 1552 M-H, Fixed *1.87 [1.31, 2.67] 48% 
Diabetes 7 2149 M-H, Random 1.40 [0.86, 2.27] 69% 
Hypertension 7 2149 M-H, Fixed 1.25 [0.95, 1.64] 48% 
Ischaemic Heart Disease 2 979 M-H, Random 0.99 [0.35, 2.85] 85% 
Depression 3 1306 M-H, Fixed *2.82 [1.59, 4.99] 27% 
Cognitive Impairment 3 946 M-H, Fixed *6.52 [3.39, 12.53] 19% 
Cardiac Comorbidity 3 597 M-H, Random 2.43 [0.97, 6.12] 76% 
  
Pulmonary Comorbidity 2 298 M-H, Random 0.95 [0.30, 2.99] 61% 
COPD 2 860 M-H, Fixed 1.42 [0.67, 3.02] 0% 
End Stage Renal Disease 2 696 M-H, Fixed 2.01 [1.00, 4.05] 0% 
Scoring Systems      
ASA Score 3 307 IV, Fixed *0.14 (0.01, 0.26) 47% 
ASA>2 5 1180 M-H, Fixed *3.44 [2.02, 5.87] 49% 
HAMD 2 200 IV, Fixed *3.12 (1.64, 4.60) 0% 
BPRS 2 200 IV, Fixed *4.79 (2.46, 7.11) 0% 
ASGS 2 200 IV, Fixed *0.79 (0.50, 1.08) 0% 
GAS 2 200 IV, Fixed *-9.58 (-13.34, -
5.81) 
0% 
MMSE 2 200 IV, Fixed *-1.36 (-2.08, -
0.64) 
0% 
CCI 3 526 IV, Fixed *1.21 (0.80, 1.61) 25% 
SNAQ≥3 2 291 M-H, Fixed *2.26 [1.15, 4.43] 0% 
HDS-R≤20 2 409 M-H, Fixed *0.31 [0.18, 0.54] 0% 
Peri/Post-Operative Factors      
Emergency Operation 2 607 M-H, Random *4.09 [1.09, 15.33] 82% 
  
Elective Operation 2 607 M-H, Random 0.24 [0.07, 0.92] 82% 
General Anaesthesia 5 1461 M-H, Fixed 0.94 [0.69, 1.29] 46% 
Regional Anaesthesia 2 970 M-H, Fixed 1.36 [0.76, 2.41] 0% 
Admission to ICU 3 511 M-H, Fixed *2.61 [1.28, 5.33] 0% 
Days in ICU 5 519 IV, Random *1.06 (0.39, 1.73) 60% 
Days in Hospital 3 362 IV, Random 8.68 (-2.68, 20.05) 92% 
Early Redo Surgery 2 452 M-H, Random 0.89 [0.11, 7.17] 77% 
Minimal Post Op Hb (g/dl) 2 200 IV, Fixed *-1.30 (-1.79, -
0.81) 
0% 
Minimal Day 1 Post Op Hb 
(g/dl) 
2 260 IV, Fixed -0.28 (-0.73, 0.16) 0% 
No of Complications 2 384 IV, Random 1.29 (-0.67, 3.25) 96% 
Length of Op (min) 4 472 IV, Fixed 16.09 (-0.98, 
33.17) 
48% 
Aortic Cross Clamp Time 
(min) 
2 255 IV, Fixed *8.11 (2.05, 14.17) 0% 
Blood Loss (ml) 3 307 IV, Fixed *992.57 (558.95, 
1426.19) 
0% 
  
Minimal Intra-op Hb (g/dl) 2 200 IV, Fixed *-1.46 (-2.12, -
0.79) 
0% 
Intra Op Blood Transfusion 2 409 M-H, Fixed *2.44 [1.58, 3.76] 0% 
Supplementary Table II: Meta -Analysis of Risk Factors. *(p<0.05). OR- Odds Ratio, MD – 
Mean Difference, I2 – Higgins I2 measurement of heterogeneity. BMI – body mass index, BP – 
blood pressure, Hb – Haemoglobin, eGFR – estimated glomerular filtration rate, COPD – 
chronic obstructive pulmonary disease, HAMD - Hamilton Depression Scale, BPRS - Brief 
Psychiatric Rating Scale, ASGS - General Severity Score, MMSE - Mini-Mental-State-
Examination, GAS - Global Assessment Scale, CCI – Charlson Comorbidity Index, M-H – 
Mantel–Haenszel, IV – Inverse-Variance. 
  
  
 
